Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 208 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Tziomalos, Konstantinos [Clear All Filters]
Serum uric acid as an independent predictor of early death after acute stroke..
Circ J. 71(7), 1120-7.
(2007). Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients..
J Clin Hypertens (Greenwich). 16(4), 309-12.
(2014). Should adipokines be considered in the choice of the treatment of obesity-related health problems?.
Curr Drug Targets. 11(1), 122-35.
(2010). Should all hypertensive patients be screened for primary aldosteronism?.
Curr Hypertens Rev.
(2018). Should atenolol still be recommended as first-line therapy for primary hypertension?.
Hellenic J Cardiol. 47(5), 298-307.
(2006). Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke..
Cardiovasc Hematol Disord Drug Targets. 18(2), 134-138.
(2018). Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism..
Expert Opin Pharmacother. 9(4), 509-15.
(2008). Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival..
Hepatol Res. 40(2), 161-70.
(2010). Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?.
Curr Med Res Opin. 26(4), 839-42.
(2010). Statin-fibrate combination for mixed dyslipidaemia: a limited option?.
Curr Med Res Opin. 26(9), 2137-40.
(2010). Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients..
Open Cardiovasc Med J. 1, 8-14.
(2007). Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention..
Curr Vasc Pharmacol. 7(3), 264-6.
(2009). Statins for the prevention of first or recurrent stroke..
Curr Vasc Pharmacol. 6(2), 124-33.
(2008). Stress hyperglycemia and acute ischemic stroke in-hospital outcome..
Metabolism. 67, 99-105.
(2017). Targeting vascular risk in patients with metabolic syndrome but without diabetes..
Metabolism. 54(8), 1065-74.
(2005). Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?.
Arch Med Sci. 7(6), 1067-75.
(2011). To switch (statins) or not to switch? That is the question..
Expert Opin Pharmacother. 11(18), 2943-6.
(2010). Treatment of congenital fibrinogen deficiency: overview and recent findings..
Vasc Health Risk Manag. 5, 843-8.
(2009). Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with administration of octreotide LAR and propranolol..
Hormones (Athens). 3(1), 65-7.
(2004). Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy..
Expert Rev Cardiovasc Ther. 13(9), 1059-66.
(2015). Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity..
Cerebrovasc Dis. 41(5-6), 226-32.
(2016). Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema..
Am J Cardiovasc Drugs. 18(5), 397-403.
(2018). Triglycerides and vascular risk: insights from epidemiological data and interventional studies..
Curr Drug Targets. 10(4), 320-7.
(2009). Type 2 diabetes is associated with a worse functional outcome of ischemic stroke..
World J Diabetes. 5(6), 939-44.
(2014).
(2005).